Method for the delivery of a biologically active agent
AssigneeHealth Plus International Inc.
InventorVan de Casteele Russell
Life of this patent
Estimating the term…
Abstract
A method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed. A microfluidizable mixture is initially formed and processed via a microfluidization process to form the stable nanosuspension, which may be administered via the buccal mucosa or other suitable routes of administration. This product demonstrates increased bioavailability, enhanced period of onset, and enhanced stability for a controlled-release product.
Claims17
A method for administration of a biologically active agent to a subject via a buccal mucosal route comprising:
- forming, via a microfluidization process, a stable nanosuspension comprising nanodroplets of at least one biologically active agent;
- and
- contacting said nanosuspension with the buccal mucosa of said subject;
- wherein said biologically active agent is absorbed into the bloodstream of said subject.
A method for administration of a microfluidized nanosuspension containing a biologically active agent to a subject comprising:
- forming, via a microfluidization process, a stable nanosuspension comprising nanodroplets of at least one biologically active agent;
- and
- administering said nanosuspension to said subject;
- wherein said biologically active agent is absorbed into the bloodstream of said subject.
Dependencies are inferred from the claim text.